IRB Barcelona collaborates with Amazon in the development of a computational tool

(Institute for Research in Biomedicine (IRB Barcelona)) The tool is based on Chemical Checker technology, developed by the Structural Bioinformatics and Network Biology Laboratory at IRB Barcelona.The aim is to use artificial intelligence to generate a drug database that includes all the published scientific results related to the treatment of COVID-19.This open access database will provide researchers from around the world with an expanded portfolio of molecules with the potential to fight COVID-19.
Source: EurekAlert! - Biology - Category: Biology Source Type: news